TECHNETIUM TC 99M SULFUR COLLOID
LOE ApproachingNDAINJECTION, ORALSOLUTION
Approved
Sep 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNETIUM TC 99M SULFUR COLLOID by GE HealthCare is 99m decays by isomeric transition, emitting a photon that can be detected for imaging purposes. First approved in 1974.
Drug data last refreshed 3d ago
Mechanism of Action
99m decays by isomeric transition, emitting a photon that can be detected for imaging purposes. Following subcutaneous injection, Technetium Tc 99m Sulfur Colloid enters the lymphatic capillaries and is transported with lymph to lymph nodes. However, when there is massive nodal metastatic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Worked on TECHNETIUM TC 99M SULFUR COLLOID at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.